Renal responses to AT1 receptor blockade

American Journal of Hypertension

Volumn 13, Issue 1 II SUPPL., 2000, Pages

  Navar, L Gabriel ^a   Harrison Bernard, Lisa M ^a   Imig, John D ^a   Cervenka, Ludek ^a   Mitchell, Kenneth D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candesartan; Renal hemodynamics; Renal hypertension; Sodium excretion; Tubular Ang II concentration; Two kidney one clip Goldblatt hypertension

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; CANDESARTAN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RECEPTOR BLOCKING; RENOVASCULAR HYPERTENSION; REVIEW; TISSUE DISTRIBUTION; TISSUE LEVEL; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; KIDNEY; KIDNEY CIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; HYPERTENSION, RENAL; KIDNEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; TETRAZOLES;

EID: 0033630217     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00248-4     Document Type: Review

References (83)

1. Burnier M, Waeber B, Brunner HR: The advantages of angiotensin II antagonism. J Hypertens 1994;12(suppl 2):S7-S15.
2. Yamamoto K, Chappell MC, Broshnihan KB, Ferrario CM: In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992;19:692-696.
3. Harding JW, Wright JW, Swanson GN, Hanesworth JM, Krebs LT: AT4 receptors: specificity and distribution. Kidney Int 1994;46:1510-1512.
4. Mitchell KD, Navar LG: Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edition. New York, Raven Press, 1995, pp 1437-1450.
5. Navar LG: The kidney in blood pressure regulation and development of hypertension. Med Clin N Am 1997; 81:1165-1198.
6. Brasier AR, Li J: Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 1996;27(part 2):465-475.
7. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ: Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991;18:763-773.
8. Zou L, Imig JD, Von Thun AM, Hymel A, Ono H, Navar LG: Receptor-mediated intrarenal ANG II augmentation in ANG II-infused rats. Hypertension 1996; 28:669-677.
9. Erdos EG: Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-370.
10. Mitchell KD, Navar LG: The renin-angiotensin-aldosterone system in volume control, in Baylis PH (ed): Bailliere's Clinical Endocrinology and Metabolism, 2nd edition. London, Bailliere Tindall, 1989, pp 393-430.
11. Ichikawa I, Harris RC: Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int 1991;40:583-596.
12. Corvol P, Jeunemaitre X, Charru A, Kotelevtsev Y, Soubrier F: Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. Rec Prog Hormone Res 1995;50:287-308.
13. Ferrario CM, Flack JM: Pathologic consequences of increased angiotensin II activity. Cardiovasc Drugs Ther 1996;10:511-518.
14. Griendling KK, Ushio-Fukai M, Lassègue B, Alexander RW: Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997;29(part 2):366-373.
15. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3:1531-1540.
16. Wolf G, Ziyadeh F: The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997;29:153-163.
17. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Investig 1997;100:264-269.
18. Douglas JG: Angiotensin receptor subtypes of the kidney cortex. Am J Physiol (Renal Fluid Electrolyte Physiol 22) 1987;253:F1-F7.
19. 1 angiotensin II receptor that is present in proximal tubule epithelium. Am J Physiol (Renal Fluid Electrolyte Physiol 33) 1993;264:F645-F654.
20. 1 receptor. Am J Physiol (Renal Fluid Electrolyte Physiol 33) 1993;264:F989-F995.
21. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol (Renal Fluid Electrolyte Physiol 41) 1997;273:F170-F177.
22. Schulz WW, Hagler HK, Buja LM, Erdos EG: Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Laboratory Investigation 1988;59:789-797.
23. Danser AHJ, Koning MMG, Admiraal PJJ, Sassen LM, Derkx FH, Verdouw PD, Schalekamp MA: Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol (Heart Circ Physiol 32) 1992;263:H429-H437.
24. Johnston CI: Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994;23:258-268.
25. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.
26. Campbell DJ: Differential regulation of angiotensin peptides in plasma and kidney: effects of adrenalectomy and estrogen treatment. Clin Exper Hypertens 1997;19:687-698.
27. Müller DN, Bohlender J, Hilgers KF, Dragun D, Costerousse O, Menard J, Luft FC: Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 1997;29:98-104.
28. Zimmerman BG, Dunham EW: Tissue renin-angiotensin system: a site of drug action? Ann Rev Pharmacol Toxicol 1997;37:53-69.
29. De Silva PE, Husain A, Smeby RR, Khairallah PA: Measurement of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis. Analytic Biochem 1988;174:80-87.
30. Fox J, Guan S, Hymel AA, Navar LG: Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol (Renal Fluid Electrolyte Physiol 31) 1992;262:F902-F909.
31. Rosivall L, Narkates AJ, Oparil S, Navar LG: De novo intrarenal formation of angiotensin II during control and enhanced renin secretion. Am J Physiol 1987;252: F1118-F1123.
32. Navar LG, Imig JD, Zou L, Wang CT: Intrarenal production of angiotensin II. Sem Nephrol 1997;17:412-422.
33. Gomez RA, Lynch KR, Chevalier RL, Everett AD, Johns DW, Wilfong N, Peach MJ, Carey RM: Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (Renal Fluid Electrolyte Physiol 23) 1988;254:F900-F906.
34. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ: In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 1990;85:417-423.
35. Darby IA, Sernia C: In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res 1995;281:197-206.
36. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS: Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol (Renal Physiol 45) 1999;276:F218-F227.
37. Guan S, Fox J, Mitchell KD, Navar LG: Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one-clip hypertensive rats. Hypertension 1992; 20:763-767.
38. Von Thun AM, Vari RC, El-Dahr SS, Navar LG: Augmentation of intrarenal angiotensin II levels by chronic II infusion. Am J Physiol (Renal Fluid Electrolyte Physiol 35) 1994;266:F120-F128.
39. Jin D, Takai S, Shiota N, Miyazaki M: Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters. J Hypertens 1998;16:657-664.
40. Hunt MK, Ramos SP, Geary KM, Norling LL, Peach MJ, Gomez RA, Carey RM: Colocalization and release of angiotensin and renin in renal cortical cells. Am J Physiol (Renal Fluid Electrolyte Physiol 32) 1992;263: F363-F373.
41. Terada Y, Tomita K, Nonoguchi H, Marumo F: PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 1993;43: 1251-1259.
42. Cogan MG: Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990;15:451-458.
43. Li L, Wang Y-P, Capparelli AW, Jo OD, Yanagawa N: Effect of luminal angiotensin II on proximal tubule fluid transport: role of apical phospholipase A2. Am J Physiol (Renal Fluid Electrolyte Physiol 35) 1994;266: F202-F209.
44. Quan A, Baum M: Endogenous production of angiotensin II modulates rat proximal tubule transport. J Clin Invest 1996;97:2878-2882.
45. Baum M, Quigley R, Quan A: Effect of luminal angiotensin II on rabbit proximal convoluted tubule bicarbonate absorption. Am J Physiol (Renal Fluid Electrolyte Physiol 42) 1997;273:F595-F600.
46. Seikaly MG, Arant BS Jr, Seney FD Jr: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990;86:1352-1357.
47. Braam B, Mitchell KD, Fox J, Navar LG: Proximal tubular secretion of angiotensin II in rats. Am J Physiol (Renal Fluid Electrolyte Physiol 33) 1993;264:F891-F898.
48. Navar LG, Lewis L, Hymel A, et al: Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol 1994;5: 1153-1158.
49. Navar LG, Lewis L, Hymel A, et al: Proximal tubular fluid levels of angiotensinogen in anesthetized rats (abst). FASEB J 1996;10:A22.
50. Moe OW, Ujiie K, Star RA, Miller RT, Widell J, Alpern RJ, Henrich WL: Renin expression in renal proximal tubule. J Clin Investig 1993;91:774-779.
51. Henrich WL, McAllister EA, Eskue A, Miller T, Moe OW: Renin regulation in cultured proximal tubular cells. Hypertension 1996;27:1337-1340.
52. Leyssac PP: Changes in single nephron renin release are mediated by tubular fluid flow rate. Kidney Int 1986;30:332-339.
53. Ikemoto F, Ito S, Song G, Tanaka M, Takada T, Tominaga M, Hiruma M, Nakamura N, Yamamoto K: Contribution of renal angiotensin converting enzyme (ACE) to blood pressure regulation: possible role of brush border ace. Clin Exper Theory Practice 1987;9: 441-447.
54. Sibony M, Gasc J-M, Soubrier F, Alhenc-Gelas F, Corvol P: Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 1993;21:827-835.
55. Wang C-T, Zou L, Navar LG: Proximal tubular fluid angiotensin II concentrations in non-clipped kidneys of 2-kidney 1-clip hypertensive rats (abst). J Am Soc Nephrol 1996;7:1544.
56. Mitchell KD, Jacinto SM, Mullins JJ: Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol (Renal Fluid Electrolyte Physiol 42) 1997;273:F246-F253.
57. Wang C-T, Mitchell KD, Navar LG: Proximal tubular fluid angiotensin II levels in angiotensin II-infused hypertensive rats (abst). J Am Soc Nephrol 1997;8:1428.
58. 3 flux by VIP, isoproterenol, angiotensin II, and ADH. Am J Physiol (Renal Fluid Electrolyte Physiol 35) 1994;266: F878-F883.
59. Levine DZ, lacovitti M, Buckman S, Burns KD: Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo. J Clin Invest 1996;97: 120-125.
60. Wang T, Giebisch G: Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am J Physiol (Renal Fluid Electrolyte Physiol 40) 1996;271:F143-F149.
61. - reabsorption. Am J Physiol (Renal Fluid Electrolyte Physiol 40) 1996;271:F977-F984.
62. Mitchell KD, Braam B, Navar LG: Hypertensinogenic mechanisms mediated by renal actions of renin-angiotensin system. Hypertension 1992;19(suppl I):I18-I27.
63. Navar LG, Hamm LL. The kidney in blood pressure regulation, in Wilcox CS (ed): Atlas of Diseases of the Kidney. Hypertension and the Kidney. Philadelphia, Current Medicine, 1999, pp 1.1-1.22.
64. Kline RL, Liu F: Modification of pressure natriuresis by long-term losartan in spontaneously hypertensive rats. Hypertension 1994;24:467-473.
65. Braam B, Navar LG, Mitchell KD: Modulation of tubuloglomerular feedback by angiotensin II type 1 receptors during the development of Goldblatt hypertension. Hypertension 1995;25:1232-1237.
66. 1 receptor blockade by candesartan on arterial pressure and renal function in rats. Am J Physiol (Renal Physiol 43) 1998;274:F940-F945.
67. Cervenka L, Navar LG: Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan. J Am Soc Nephrol 1999;10:S196-S201.
68. El-Dahr SS, Dipp S, Guan S, Navar LG: Renin, angiotensinogen, and kallikrein gene expression in two-kidney Goldblatt hypertensive rats. Am J Hypertens 1993; 6:914-919.
69. 1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension 1999;33:102-107.
70. Amiri F, Garcia R: Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats. Effect of ACE inhibition. Hypertension 1997;30(part 1):337-344.
71. Cheng H-F, Becker BN, Burns KD, Harris RC: Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 1995;95:2012-2019.
72. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG: Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999;33(part II):340-346.
73. Inscho EW, Carmines PK, Cook AK, Navar LG: Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension. Hypertension 1990;15:748-752.
74. Ichihara A, Inscho EW, Imig JD, Michel RE, Navar LG: Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Hypertension 1997; 29(part 2):442-449.
75. Inscho EW, Imig JD, Deichmann PC, Cook AK: Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats. J Am Soc Nephrol 1999;10:S178-S183.
76. 2-purinoceptor activation. Am J Physiol (Renal Fluid Electrolyte Physiol 40) 1996;271:F1077-F1085.
77. Kawabata M, Takabatake T, Ohta H, Nakamura S, Hara H, Ohta K, Takakuwa H, Han WH, Kobayashi K: Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension. Blood Pressure 1994;3(suppl 5):117-121.
78. Gansevoort RT, deZeeuw D, deJong PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994; 45:861-867.
79. Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M: Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens 1998;16:385-393.
80. Carmines PK, Perry MD, Hazelrig JB, Navar LG: Effects of preglomerular and postglomerular vascular resistance alterations on filtration fraction. Kidney Int 1987; 31(suppl 20):S229-S232.
81. Arendshorst WJ, Navar LG: Renal circulation and glomerular hemodynamics, in Schrier RW, Gottschalk CW (eds): Diseases of the Kidney, 6th edition. Boston, Little Brown, 1997, pp 59-106.
82. Burnier M, Rutschmann B, Nussberger J, Versaggi J, Shahinfar S, Waeber B, Brunner HR: Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension 1993;22:339-347.
83. Guyton AC: Blood pressure control - special role of the kidneys and body fluids. Science 1991;252:1813-1816.